000 | 01521 a2200481 4500 | ||
---|---|---|---|
005 | 20250515225103.0 | ||
264 | 0 | _c20100707 | |
008 | 201007s 0 0 eng d | ||
022 | _a0890-9016 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLonze, Bonnie E | |
245 | 0 | 0 |
_aThe fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib. _h[electronic resource] |
260 |
_bClinical transplants _c2009 |
||
300 |
_a377-84 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 |
_aBoronic Acids _xtherapeutic use |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 | _aCadaver |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHLA Antigens _ximmunology |
650 | 0 | 4 |
_aHLA-D Antigens _ximmunology |
650 | 0 | 4 |
_aHLA-DQ Antigens _ximmunology |
650 | 0 | 4 |
_aHistocompatibility Antigens Class I _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _xsurgery |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 | _aLiving Donors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProtease Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
650 | 0 | 4 | _aTissue Donors |
700 | 1 | _aDagher, Nabil N | |
700 | 1 | _aSimpkins, Christopher E | |
700 | 1 | _aSinger, Andrew L | |
700 | 1 | _aSegev, Dorry L | |
700 | 1 | _aZachary, Andrea A | |
700 | 1 | _aMontgomery, Robert A | |
773 | 0 |
_tClinical transplants _gp. 377-84 |
|
999 |
_c19874894 _d19874894 |